The short version

From the latest prices and each company's SEC filings. Who's ahead on each measure, not which to buy.

  • Coca-Cola Femsa SAB de CV ADR is the larger company, worth $23.0B, about 2.9 times Celsius.
  • Coca-Cola Femsa SAB de CV ADR grew revenue faster over the last year (+14.2% vs +10.6%).

Side by side

The stronger figure is shaded where higher (or, for valuation multiples, lower) reads as better. How the implied growth works.

MeasureCELHKOF
Market cap$7.9B$23.0B
Share price$28.58$109.86
Revenue (last fiscal year)$2.5B$279.8B
Free cash flow (last fiscal year)$323M$16.6B
Revenue growth, last year+10.6%+14.2%
Revenue growth per year, last 5 fiscal years+68.2%+11.1%
Operating margin5.3%—
Net margin4.2%8.5%
Return on equity10.8%19.3%
P/E (trailing)72.0x—
Price / free cash flow24.5x4.02x
EV / EBITDA44.4x10.4x
FCF growth the price implies7.6%—
Dividend yield—3.7%
Debt / equity1.84x1.04x
Fundamental gradeDC
Superinvestors holding it45
Insider purchases, last 12 months50

Results from SEC filings

Revenue and free cash flow by fiscal year, from each company's 10-K filings.

Celsius

YearRevenueFree cash flowOp. margin
2021$314M-$100M-1.3%
2022$654M$100M-24.1%
2023$1.3B$124M20.2%
2024$1.4B$240M11.5%
2025$2.5B$323M5.6%

Coca-Cola Femsa SAB de CV ADR

YearRevenueFree cash flowOp. margin
2020$183.6B$25.2B—
2021$194.8B$22.7B—
2022$226.7B$17.8B—
2023$245.1B$21.7B—
2024$279.8B$16.6B—

Where the revenue comes from

Celsius · by regions, 2025

North America$2.4B96%
Europe$73M3%
Asia-Pacific$13M1%
Other$7M0%

Coca-Cola Femsa SAB de CV ADR · by products, 2025

Sale of products$291.1B100%
Other operating revenues$519M0%
Services rendered$80M0%
Compare them in fullFifteen years of statements, quarterly results, DCF and IRR models, and any number of peers side by side.
Open CELH in Investingly

Questions

Which is bigger, Celsius or Coca-Cola Femsa SAB de CV ADR?

Coca-Cola Femsa SAB de CV ADR (KOF), at $23.0B against $7.9B.

Which grows faster, CELH or KOF?

Coca-Cola Femsa SAB de CV ADR: revenue grew +14.2% over the last year, against +10.6%.

Prices and ratios as of the last daily update; statements from SEC filings. Information only, not investment advice.